Clinical Trials Browser

Phase 3 × Hormone Refractory Prostate Cancer × Denosumab × Clear all

NCT00286091 2018-10-17

Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer

Phase 3 Completed

1,435 enrolled 15 charts

Hormone Refractory Prostate Cancer